Lookup NU author(s): Dr Christopher Duncan,
Professor Sophie Hambleton
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Varicella zoster (VZV) is among the most prevalent viruses affecting the human race. The majority of us experience primary infection as varicella in childhood and remain latently infected, with occasional reactivation as the infectious entity, shingles. Rarely, VZV causes severe and disseminated disease, which can be fatal despite the availability of highly active antiviral agents. VZV is the only herpesvirus against which effective vaccines have been developed and widely implemented in several countries, further complicating its epidemiology. The immunological correlates of protection against varicella remain incompletely understood. Here we provide a brief overview of evidence from animal models and observational studies that define immunologic risk factors for severe varicella, and thus the most important elements of VZV immunity. Although circulating VZV-specific antibody can prevent primary infection, innate and cellular responses appear much more important in limiting its severity and duration. Improved understanding of these protective factors may assist us in developing more effective strategies for the prevention and treatment of severe varicella.
Author(s): Duncan CJA, Hambleton S
Publication type: Review
Publication status: Published
Journal: Journal of Infection
Issue: Suppl. 1
Print publication date: 22/06/2015
Online publication date: 25/04/2015
Acceptance date: 21/04/2015
ISSN (print): 0163-4453
ISSN (electronic): 1532-2742
PubMed id: 25917799